Les publications du programme ELIPS à Genève aux HUG

P.-F. Keller V. Barthassat F. Scherrer-Burri G. Lagger S. Carballo.- Combattre l’infarctus du myocarde et l’athérosclérose : un défi thérapeutique in : Revue Médicale Suisse, mai 2008, n°3159
Pierre-Frédéric Keller, Alain Golay, René Lerch, François Mach.- Le chaînon manquant dans le traitement du syndrome coronarien aigu: l’éducation thérapeutique in : Kardiovaskuläre Medizin, 2008;11:5–6
Daily News de l'euroPCR - article principal paru dans le journal du congrès de l'EuroPCR Patient Education with the ELIPS® programme
D. Carballo, R. Auer, S. Carballo, S. Windecker, C. Matter,T. Luscher, P. Vogt, T. Perneger, F. Mach, N. Rodondi, P-F Keller au nom du consortium SPUM-ACS.- Un projet multicentrique suisse pour améliorer la prévention et la récidive après un syndrome coronarientitan.medhyg.ch/mh/formation/article.php3 aigu in : Revue Médicale Suisse, mars 2010, n°239
R. Auer, B. Gencer, L. Raber, R. Klingenberg, S. Carballo, D. Carballo, D. Nanchen, J. Cornuz, JP. Vader, P. Vogt, et al.- Quality of care after acute coronary syndromes in a perspective cohort with reasons for non-prescription of recommanded medications in : PloS one, 2014 ; 9:e93147.
B. Gencer, R. Auer, D. Nanchen, L. Räber, R. Klingenberg, D. Carballo, M. Blum, P. Vogt, S. Carballo, P. Meyer, et al. - Expected impact of applying new 2013 AHA/ACC Cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes in Atherosclerosis. 2015; 239: 118-124.
L. Räber, R. Klingenberg, D. Heg, H. Kelbaek, M. Roffi, D. Tüller, A. Baumbach, T. Zanchin, D. Carballo, M. Ostojic, et al. for COMFORTABLE and SPUM-ACS Trial Investigators.- Safety of prasugrel loading doses in patients pre-loaded with clopidogrel in the setting of primary percutaneous coronary intervention: results of a Nonrandomized observational study. in : JACC: Cardiovascular interventions. 2015; 8:1064-1074
R. Klingenberg, D. Heg, L. Räber, D. Carballo, D. Nanchen, B. Gencer, R. Auer, M. Jaguszewski, B.E. Stähli, P. Jakob, et al.- Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland in Heart, 2015; 101:854-863.
K. Selby, D. Nanchen, R. Auer, B. Gencer, L. Räber, R. Klingenberg, M. Blum, P. Marques-Vidal, J. Cornuz, O. Muller, et al. - Low Statin use in adults hospitalized with acute coronary syndrome in Preventive medicine, 2015; 77:131-136
B. Gencer, F. Montecucco, D. Nanchen, F. Carbone, R. Klingenberg, N. Vuilleumier, D. Heg, L. Räber, R. Auer, P. Jüni, et al.- Prognostic role of proprotein convertase subtilism kexin 9 levels in patients with acute coronary syndromes and association with familial hypercholesterolemia in : Eur Heart J. 2015 Dec 9. pii: ehv637.
D. Nanchen, B. Gencer, R Auer, L. Raber, GG. Stefanini, R. Klingenberg, CM. Schmied, J. Cornuz, O. Muller, P. Vogt, et al.- Prevalence and management of familial hypercholesterolemia in patients with acute coronary syndromes in : European Heart Journal.36, 2438-2445.
Gencer B, Rodondi N, Auer R, Raber L, Klingenberg R, Nanchen D, Carballo D, Vogt P, Carballo S, Meyer P, et al.- Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes in European journal of internal medicine. 2015;26:56-62.
B. Gencer, N. Rodondi, R. Auer, D. Nanchen, L. Räber, R. Klingenberg, M. Pletscher, P. Jüni, S. Windecker, C. Matter, et al.- Health utility indexes in patients with aute coronary syndromes in Open Heart.2016;3:e000419.doi:10.1136
J. Welker, R. Auer, B. Gencer, O. Muller, J. Cornuz, F. Mach, S. Windecker, N. Rodondi, D. Nanchen.- Hospital revascularisation capability and quality of care after an acute coronary syndrome in Swizterland in Swiss Medical Weekly. Feb 2016. DOI: 10.4414/smw.2016.14275
B. Gencer, D. Nanchen.- Identifying familial hypercholesterolemia in acute coronary syndrome in Current Opinion in Lipidology, April 2016, DOI.:10.1097
D. Nanchen, B. Gencer, O. Muller, R. Auer, S. Aghlmandi, D. Heg, R. Klingenberg, L. Räber, D. Carballo, S. Carballo, et al.- Prognosis of Patient with Familial Hypercholesterolemia After Acute Coronary Syndromes in Circulation. 2016 Jul 26.
R. Auer, B. Gencer, R. Tango, D. Nanchen, C.M Matter, TF. Lüscher, S. Windecker, F. Mach, J. Cornuz, JP. Humair, N. Rodondi.- Acceptability and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalized for acute coronary syndromes in BMJ Open. 2016 Sep 20;6(9):e011520
MC. Laurence, F. Girardin, F. Rigamonti, A. Bevand, P. Meyer, M. Roffi, S. Noble, F. Mach, B. Gencer.- Early discharge in low-risk patients hospitalized for acute coronary syndromes: feasibility, safety and reasons for prolonged length of stay in PLoS One. 2016 Aug 23;11(8):e0161493
B. Gencer, N. Rodondi, F. Mach.- New concepts in the management of dyslipidemia. in Swiss Medical Weekly.2016 Nov 12;146:w14378
B. Gencer, KC. Koskinas, L. Räber, A. Karagiannis, D. Nanchen, R. Auer, D. Carballo, S. Carballo, R. Klingenberg, D. Heg, et al.- Eligibility for PCSK9 inhibitors According to ACC and ESC/EAS guidelines after Acute Coronary Syndromes in J Am Heart Assoc. 2017 Nov 9;6(11).
B. Gencer, F. Mach.- So low....so far so good: neurocognitive impact of lowering LDL-C levels with PCSK9 inhibitors in European Heart Journal. 2018 Jan 16;39: 382-384
D. Carballo, N. Rodondi, R. Auer, S. Carballo, D. Nanchen, L. Räber, R. Klingenberg, P-F. Keller, D. Heg, P. Jüni, et al.- Clinical impact of a structured secondary cardiovascular prevention program followin acute coronary syndromes : A prospective multicenter healthcare intervention in : PloS one, 21.02.2019; e0211464.

Publications

Plus d'informations